B. Dingle

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 407 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +11

Acute nickel toxicity in electroplating workers who accidently ingested a solution of nickel sulfate and nickel chloride

F. William Sunderman, B. Dingle, Sidney M. Hopfer et al. · American Journal of Industrial Medicine · 1988 · 156 citations

CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy

Wendy A. Teft, Inna Y. Gong, B. Dingle et al. · Breast Cancer Research and Treatment · 2013 · 77 citations

Medicine, Tamoxifen Therapy, Vitamin D Status +4

Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial

Douglas A. Hoover, Dante P. I. Capaldi, Khadija Sheikh et al. · BMC Cancer · 2014 · 60 citations · Full text